2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. / Furer, Victoria; Rondaan, Christien; Heijstek, Marloes W.; Agmon-Levin, Nancy; Van Assen, Sander; Bijl, Marc; Breedveld, Ferry C.; D'amelio, Raffaele; Dougados, Maxime; Kapetanovic, Meliha Crnkic; Van Laar, Jacob M.; De Thurah, A.; Landewé, Robert B.M.; Molto, Anna; Müller-Ladner, Ulf; Schreiber, Karen; Smolar, Leo; Walker, Jim; Warnatz, Klaus; Wulffraat, Nico M.; Elkayam, Ori.

I: Annals of the Rheumatic Diseases, Bind 79, Nr. 1, 2020, s. 39-52.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Furer, V, Rondaan, C, Heijstek, MW, Agmon-Levin, N, Van Assen, S, Bijl, M, Breedveld, FC, D'amelio, R, Dougados, M, Kapetanovic, MC, Van Laar, JM, De Thurah, A, Landewé, RBM, Molto, A, Müller-Ladner, U, Schreiber, K, Smolar, L, Walker, J, Warnatz, K, Wulffraat, NM & Elkayam, O 2020, '2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases', Annals of the Rheumatic Diseases, bind 79, nr. 1, s. 39-52. https://doi.org/10.1136/annrheumdis-2019-215882

APA

Furer, V., Rondaan, C., Heijstek, M. W., Agmon-Levin, N., Van Assen, S., Bijl, M., Breedveld, F. C., D'amelio, R., Dougados, M., Kapetanovic, M. C., Van Laar, J. M., De Thurah, A., Landewé, R. B. M., Molto, A., Müller-Ladner, U., Schreiber, K., Smolar, L., Walker, J., Warnatz, K., ... Elkayam, O. (2020). 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Annals of the Rheumatic Diseases, 79(1), 39-52. https://doi.org/10.1136/annrheumdis-2019-215882

CBE

Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, Van Assen S, Bijl M, Breedveld FC, D'amelio R, Dougados M, Kapetanovic MC, Van Laar JM, De Thurah A, Landewé RBM, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O. 2020. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Annals of the Rheumatic Diseases. 79(1):39-52. https://doi.org/10.1136/annrheumdis-2019-215882

MLA

Vancouver

Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, Van Assen S, Bijl M o.a. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Annals of the Rheumatic Diseases. 2020;79(1):39-52. https://doi.org/10.1136/annrheumdis-2019-215882

Author

Furer, Victoria ; Rondaan, Christien ; Heijstek, Marloes W. ; Agmon-Levin, Nancy ; Van Assen, Sander ; Bijl, Marc ; Breedveld, Ferry C. ; D'amelio, Raffaele ; Dougados, Maxime ; Kapetanovic, Meliha Crnkic ; Van Laar, Jacob M. ; De Thurah, A. ; Landewé, Robert B.M. ; Molto, Anna ; Müller-Ladner, Ulf ; Schreiber, Karen ; Smolar, Leo ; Walker, Jim ; Warnatz, Klaus ; Wulffraat, Nico M. ; Elkayam, Ori. / 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. I: Annals of the Rheumatic Diseases. 2020 ; Bind 79, Nr. 1. s. 39-52.

Bibtex

@article{8217cebe06624c1c9e3b582da4386b13,
title = "2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases",
abstract = "To update the European League Against Rheumatism (EULAR) recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) published in 2011. Four systematic literature reviews were performed regarding the incidence/prevalence of vaccine-preventable infections among patients with AIIRD; efficacy, immunogenicity and safety of vaccines; effect of anti-rheumatic drugs on the response to vaccines; effect of vaccination of household of AIIRDs patients. Subsequently, recommendations were formulated based on the evidence and expert opinion. The updated recommendations comprise six overarching principles and nine recommendations. The former address the need for an annual vaccination status assessment, shared decision-making and timing of vaccination, favouring vaccination during quiescent disease, preferably prior to the initiation of immunosuppression. Non-live vaccines can be safely provided to AIIRD patients regardless of underlying therapy, whereas live-attenuated vaccines may be considered with caution. Influenza and pneumococcal vaccination should be strongly considered for the majority of patients with AIIRD. Tetanus toxoid and human papilloma virus vaccination should be provided to AIIRD patients as recommended for the general population. Hepatitis A, hepatitis B and herpes zoster vaccination should be administered to AIIRD patients at risk. Immunocompetent household members of patients with AIIRD should receive vaccines according to national guidelines, except for the oral poliomyelitis vaccine. Live-attenuated vaccines should be avoided during the first 6 months of life in newborns of mothers treated with biologics during the second half of pregnancy. These 2019 EULAR recommendations provide an up-to-date guidance on the management of vaccinations in patients with AIIRD.",
keywords = "autoimmune diseases, infections, vaccination",
author = "Victoria Furer and Christien Rondaan and Heijstek, {Marloes W.} and Nancy Agmon-Levin and {Van Assen}, Sander and Marc Bijl and Breedveld, {Ferry C.} and Raffaele D'amelio and Maxime Dougados and Kapetanovic, {Meliha Crnkic} and {Van Laar}, {Jacob M.} and {De Thurah}, A. and Landew{\'e}, {Robert B.M.} and Anna Molto and Ulf M{\"u}ller-Ladner and Karen Schreiber and Leo Smolar and Jim Walker and Klaus Warnatz and Wulffraat, {Nico M.} and Ori Elkayam",
year = "2020",
doi = "10.1136/annrheumdis-2019-215882",
language = "English",
volume = "79",
pages = "39--52",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "1",

}

RIS

TY - JOUR

T1 - 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

AU - Furer, Victoria

AU - Rondaan, Christien

AU - Heijstek, Marloes W.

AU - Agmon-Levin, Nancy

AU - Van Assen, Sander

AU - Bijl, Marc

AU - Breedveld, Ferry C.

AU - D'amelio, Raffaele

AU - Dougados, Maxime

AU - Kapetanovic, Meliha Crnkic

AU - Van Laar, Jacob M.

AU - De Thurah, A.

AU - Landewé, Robert B.M.

AU - Molto, Anna

AU - Müller-Ladner, Ulf

AU - Schreiber, Karen

AU - Smolar, Leo

AU - Walker, Jim

AU - Warnatz, Klaus

AU - Wulffraat, Nico M.

AU - Elkayam, Ori

PY - 2020

Y1 - 2020

N2 - To update the European League Against Rheumatism (EULAR) recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) published in 2011. Four systematic literature reviews were performed regarding the incidence/prevalence of vaccine-preventable infections among patients with AIIRD; efficacy, immunogenicity and safety of vaccines; effect of anti-rheumatic drugs on the response to vaccines; effect of vaccination of household of AIIRDs patients. Subsequently, recommendations were formulated based on the evidence and expert opinion. The updated recommendations comprise six overarching principles and nine recommendations. The former address the need for an annual vaccination status assessment, shared decision-making and timing of vaccination, favouring vaccination during quiescent disease, preferably prior to the initiation of immunosuppression. Non-live vaccines can be safely provided to AIIRD patients regardless of underlying therapy, whereas live-attenuated vaccines may be considered with caution. Influenza and pneumococcal vaccination should be strongly considered for the majority of patients with AIIRD. Tetanus toxoid and human papilloma virus vaccination should be provided to AIIRD patients as recommended for the general population. Hepatitis A, hepatitis B and herpes zoster vaccination should be administered to AIIRD patients at risk. Immunocompetent household members of patients with AIIRD should receive vaccines according to national guidelines, except for the oral poliomyelitis vaccine. Live-attenuated vaccines should be avoided during the first 6 months of life in newborns of mothers treated with biologics during the second half of pregnancy. These 2019 EULAR recommendations provide an up-to-date guidance on the management of vaccinations in patients with AIIRD.

AB - To update the European League Against Rheumatism (EULAR) recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) published in 2011. Four systematic literature reviews were performed regarding the incidence/prevalence of vaccine-preventable infections among patients with AIIRD; efficacy, immunogenicity and safety of vaccines; effect of anti-rheumatic drugs on the response to vaccines; effect of vaccination of household of AIIRDs patients. Subsequently, recommendations were formulated based on the evidence and expert opinion. The updated recommendations comprise six overarching principles and nine recommendations. The former address the need for an annual vaccination status assessment, shared decision-making and timing of vaccination, favouring vaccination during quiescent disease, preferably prior to the initiation of immunosuppression. Non-live vaccines can be safely provided to AIIRD patients regardless of underlying therapy, whereas live-attenuated vaccines may be considered with caution. Influenza and pneumococcal vaccination should be strongly considered for the majority of patients with AIIRD. Tetanus toxoid and human papilloma virus vaccination should be provided to AIIRD patients as recommended for the general population. Hepatitis A, hepatitis B and herpes zoster vaccination should be administered to AIIRD patients at risk. Immunocompetent household members of patients with AIIRD should receive vaccines according to national guidelines, except for the oral poliomyelitis vaccine. Live-attenuated vaccines should be avoided during the first 6 months of life in newborns of mothers treated with biologics during the second half of pregnancy. These 2019 EULAR recommendations provide an up-to-date guidance on the management of vaccinations in patients with AIIRD.

KW - autoimmune diseases

KW - infections

KW - vaccination

UR - http://www.scopus.com/inward/record.url?scp=85070953188&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2019-215882

DO - 10.1136/annrheumdis-2019-215882

M3 - Journal article

C2 - 31413005

AN - SCOPUS:85070953188

VL - 79

SP - 39

EP - 52

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 1

ER -